Savvy Trades and Investments

[wadegarret]

R59, NOVN

The weirdest part about it all is the analysts, with price targets by HC Wainright to $28 & Roth Capital to $40 the day phase 3 was announced. Then the stock price flies to almost $21 in two days, only to crash to the $9s 3 days later, despite an $11 offering. Sure teaches me a lesson with these one horse pony biotech's, to grab a quick profit next time. Now I'm down 25% instead !

By the way, the application for the drug to treat molluscum by NOVN will be in a tube that patients can easily apply themselves, where as the drug by VRCA need be applied by a dermatologist in the office.